228 related articles for article (PubMed ID: 31774122)
1. Parathyroid Hormone and Plasma Phosphate Are Predictors of Soluble α-Klotho Levels in Adults of European Descent.
Dhayat NA; Pruijm M; Ponte B; Ackermann D; Leichtle AB; Devuyst O; Ehret G; Guessous I; Pechère-Bertschi A; Pastor J; Martin PY; Burnier M; Fiedler GM; Vogt B; Moe OW; Bochud M; Fuster DG
J Clin Endocrinol Metab; 2020 Apr; 105(4):e1135-43. PubMed ID: 31774122
[TBL] [Abstract][Full Text] [Related]
2. Circulating levels of soluble klotho and FGF23 in X-linked hypophosphatemia: circadian variance, effects of treatment, and relationship to parathyroid status.
Carpenter TO; Insogna KL; Zhang JH; Ellis B; Nieman S; Simpson C; Olear E; Gundberg CM
J Clin Endocrinol Metab; 2010 Nov; 95(11):E352-7. PubMed ID: 20685863
[TBL] [Abstract][Full Text] [Related]
3. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
Pavik I; Jaeger P; Ebner L; Wagner CA; Petzold K; Spichtig D; Poster D; Wüthrich RP; Russmann S; Serra AL
Nephrol Dial Transplant; 2013 Feb; 28(2):352-9. PubMed ID: 23129826
[TBL] [Abstract][Full Text] [Related]
4. FGF23-Klotho Axis and Fractures in Patients Without and With Early CKD: A Case-Cohort Analysis of CARTaGENE.
Desbiens LC; Sidibé A; Ung RV; Mac-Way F
J Clin Endocrinol Metab; 2022 May; 107(6):e2502-e2512. PubMed ID: 35139204
[TBL] [Abstract][Full Text] [Related]
5. In vivo evidence for an interplay of FGF23/Klotho/PTH axis on the phosphate handling in renal proximal tubules.
Ide N; Ye R; Courbebaisse M; Olauson H; Densmore MJ; Larsson TE; Hanai JI; Lanske B
Am J Physiol Renal Physiol; 2018 Nov; 315(5):F1261-F1270. PubMed ID: 29993278
[TBL] [Abstract][Full Text] [Related]
6. The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease
.
Yin C; Cheng C; Wang J; Zhang L; Purrunsing Y; Yang G; Zeng M; Huang H; Ren W; Ye Y; Ma H; Xing C; Wang N
Clin Nephrol; 2020 Feb; 93(2):65-76. PubMed ID: 31793871
[TBL] [Abstract][Full Text] [Related]
7. Soluble Klotho Protects against Uremic Cardiomyopathy Independently of Fibroblast Growth Factor 23 and Phosphate.
Xie J; Yoon J; An SW; Kuro-o M; Huang CL
J Am Soc Nephrol; 2015 May; 26(5):1150-60. PubMed ID: 25475745
[TBL] [Abstract][Full Text] [Related]
8. High serum soluble α-Klotho levels in patients with autosomal dominant polycystic kidney disease.
Sari F; Inci A; Dolu S; Ellidag HY; Cetinkaya R; Ersoy FF
J Investig Med; 2017 Feb; 65(2):358-362. PubMed ID: 27733443
[TBL] [Abstract][Full Text] [Related]
9. The FGF-23/klotho axis and its relationship with phosphorus, calcium, vitamin D, PTH, aldosterone, severity of disease, and outcome in hospitalised foals.
Kamr AM; Dembek KA; Hildreth BE; Morresey PR; Rathgeber RA; Burns TA; Zaghawa AA; Toribio RE
Equine Vet J; 2018 Nov; 50(6):739-746. PubMed ID: 29660161
[TBL] [Abstract][Full Text] [Related]
10. Assessment of tubular reabsorption of phosphate as a surrogate marker for phosphate regulation in chronic kidney disease.
Hong YA; Lim JH; Kim MY; Kim Y; Yang KS; Chung BH; Chung S; Choi BS; Yang CW; Kim YS; Chang YS; Park CW
Clin Exp Nephrol; 2015 Apr; 19(2):208-15. PubMed ID: 24682550
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor 23 and markers of mineral metabolism in individuals with preserved renal function.
Dhayat NA; Ackermann D; Pruijm M; Ponte B; Ehret G; Guessous I; Leichtle AB; Paccaud F; Mohaupt M; Fiedler GM; Devuyst O; Pechère-Bertschi A; Burnier M; Martin PY; Bochud M; Vogt B; Fuster DG
Kidney Int; 2016 Sep; 90(3):648-57. PubMed ID: 27370409
[TBL] [Abstract][Full Text] [Related]
12. Circulating levels of soluble alpha-Klotho are markedly elevated in human umbilical cord blood.
Ohata Y; Arahori H; Namba N; Kitaoka T; Hirai H; Wada K; Nakayama M; Michigami T; Imura A; Nabeshima Y; Yamazaki Y; Ozono K
J Clin Endocrinol Metab; 2011 Jun; 96(6):E943-7. PubMed ID: 21411554
[TBL] [Abstract][Full Text] [Related]
13. [Mineral metabolism in patients on chronic peritoneal dialysis].
Ceballos O ML; Rojo L A; Azócar P M; Ibacache M MJ; Delucchi B A; Quiroz Z L; Irarrázabal M C; Delgado B I; Ugarte P F; Cano Sch F
Rev Chil Pediatr; 2014 Feb; 85(1):31-9. PubMed ID: 25079181
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor 23 enhances renal klotho abundance.
Takenaka T; Watanabe Y; Inoue T; Miyazaki T; Suzuki H
Pflugers Arch; 2013 Jul; 465(7):935-43. PubMed ID: 23467972
[TBL] [Abstract][Full Text] [Related]
15. Effects of L-Carnitine on Mineral Metabolism in the Multicentre, Randomized, Double Blind, Placebo-Controlled CARNIDIAL Trial.
Mercadal L; Tezenas du Montcel S; Chonchol MB; Debure A; Depreneuf H; Servais A; Bassilios N; Assogba U; Allouache M; Prié D
Am J Nephrol; 2018; 48(5):349-356. PubMed ID: 30408788
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal Evolution of Markers of Mineral Metabolism in Patients With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
Isakova T; Cai X; Lee J; Mehta R; Zhang X; Yang W; Nessel L; Anderson AH; Lo J; Porter A; Nunes JW; Negrea L; Hamm L; Horwitz E; Chen J; Scialla JJ; de Boer IH; Leonard MB; Feldman HI; Wolf M;
Am J Kidney Dis; 2020 Feb; 75(2):235-244. PubMed ID: 31668375
[TBL] [Abstract][Full Text] [Related]
17. Fgf23 and parathyroid hormone signaling interact in kidney and bone.
Andrukhova O; Streicher C; Zeitz U; Erben RG
Mol Cell Endocrinol; 2016 Nov; 436():224-39. PubMed ID: 27498418
[TBL] [Abstract][Full Text] [Related]
18. Xeno-Klotho Inhibits Parathyroid Hormone Signaling.
Takenaka T; Inoue T; Miyazaki T; Hayashi M; Suzuki H
J Bone Miner Res; 2016 Feb; 31(2):455-62. PubMed ID: 26287968
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients.
Krajisnik T; Olauson H; Mirza MA; Hellman P; Akerström G; Westin G; Larsson TE; Björklund P
Kidney Int; 2010 Nov; 78(10):1024-32. PubMed ID: 20686451
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor 23, Klotho, and disordered mineral metabolism in chronic kidney disease: unraveling the intricate tapestry of events and implications for therapy.
Gutiérrez OM
J Ren Nutr; 2013 May; 23(3):250-4. PubMed ID: 23611556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
